BridgeMD
New treatment option for Obesity
Official title Bimbingamba Zerosix Third Phase: Studying Communities
ClinicalTrials.gov ID: NCT05859867
What this study is testing
- What it's testing
- Childhood obesity is increasing in the last years especially in developed countries, and, as well as adult obesity, is related to the development of pathologies. Unfortunately, the restoration of a normal weight condition, if the ponderal excess rose in the first years of life, seems very difficult.
- Time commitment: about 2 years
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 5
You may be able to join if
- Children aged 0-5 year of both sex resident in the two Municipalities under evaluation
- children having date of birth between 1/1/2018 and 31/12/2022 (people born 5 years prior to the start of the project)
- newborns between 01/1/2023 and 21/6/2023 residing in the two municipalities under study.
You likely can't join if
- Residence/domicile in the municipalities under investigation, for a period of time less than 6 months following recruitment;
- Recruitment of the child in other intervention trials of any nature.
The study team makes the final eligibility decision.
Where it's taking place
- Novara, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 2 years per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 2 days to 5 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Novara, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.